We are live on ! Find out more
DFTX

Definium Therapeutics

174 hedge funds and large institutions have $105M invested in Definium Therapeutics in 2021 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 17

59% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 34

18% more call options, than puts

Call options by funds: $7.82M | Put options by funds: $6.62M

12% more funds holding

Funds holding: 155174 (+19)

0.13% more ownership

Funds ownership: 0.74%0.87% (+0.13%)

20% less capital invested

Capital invested by funds: $130M → $105M (-$25.5M)

Holders
174
Holders Change
+19
Holders Change %
+12.26%
% of All Funds
3.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
54
Reduced
34
Closed
17
Calls
$7.82M
Puts
$6.62M
Net Calls
+$1.21M
Net Calls Change
-$1.76M
Name Holding Trade Value Shares
Change
Change in
Stake
AAP
151
Arax Advisory Partners
Colorado
$1K
BCM
152
Blume Capital Management
California
$1K
HWMA
153
Heritage Wealth Management (Arizona)
Arizona
$1K
LFG
154
Larson Financial Group
Missouri
$1K
PK
155
Pflug Koory
Nebraska
$1K
SBL
156
Sargent Bickham Lagudis
Colorado
$1K
AWM
157
Activest Wealth Management
Florida
$1K +$130 +3 New
TFGT
158
TS Financial Group (TSFG)
Illinois
$1K +$259 +6 +32%
CB
159
CNB Bank
Pennsylvania
$1K +$432 +10 New
PP
160
Pacifica Partners
Canada
$1K +$865 +20 New
HR
161
Howe & Rusling
New York
$1K +$1.12K +26 +520%
LTI
162
Laffer Tengler Investments
Tennessee
$233 +$303 +7 New
WIM
163
Westside Investment Management
California
$2 +$2.9K +67 New
UBS AM
164
UBS AM
Illinois
-$567K -10,867 Closed
HT
165
HAP Trading
New York
-$196K -4,537 Closed
Two Sigma Advisers
166
Two Sigma Advisers
New York
-$150K -2,900 Closed
MA
167
MYDA Advisors
New York
-$104K -2,000 Closed
EGM
168
Engineers Gate Manager
New York
-$59K -1,143 Closed
PHK
169
Point72 Hong Kong
Hong Kong
-$58K -1,121 Closed
EWA
170
EP Wealth Advisors
California
-$42K -819 Closed
OIA
171
OneDigital Investment Advisors
Kansas
-$40K -778 Closed
RJFSA
172
Raymond James Financial Services Advisors
Florida
-$36K -703 Closed
SSG
173
Summit Securities Group
New York
-$35K -667 Closed
OIA
174
Optimum Investment Advisors
Illinois
-$28K -533 Closed
PCM
175
Pinz Capital Management
New York
-$21K -413 Closed

DFTX Hedge Fund Activity: Q3 2021 in Review

174 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2021, worth a combined $105M — down 20% from $130M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new DFTX positions and 17 closed out — a net gain of 22 holders — while 54 added to existing stakes and 34 trimmed.

The largest buyer was Northern Trust, adding an estimated $6.83M. The largest seller was Jane Street, cutting an estimated $1.65M.

  • 174 institutional investors held Definium Therapeutics (DFTX) as of Q3 2021, up from 155 in Q2 2021.
  • Funds reported $105M of Definium Therapeutics stock for Q3 2021, down 20% quarter-over-quarter.
  • 39 funds opened new Definium Therapeutics positions in Q3 2021 and 17 closed out, a net change of +22 holders.
  • The largest Definium Therapeutics buyer in Q3 2021 was Northern Trust, an estimated $6.83M added.
  • The largest Definium Therapeutics seller in Q3 2021 was Jane Street, an estimated $1.65M sold.

Based on aggregated 13F filings for Q3 2021.